Products Categories
| CAS No.: | 88069-49-2 |
|---|---|
| Name: | Pilsicainide hydrochloride |
| Article Data: | 2 |
| Molecular Structure: | |
|
|
|
| Formula: | C17H24N2O.HCl |
| Molecular Weight: | 308.851 |
| Synonyms: | 1H-Pyrrolizine-7a(5H)-acetamide,N-(2,6-dimethylphenyl)tetrahydro-, monohydrochloride (9CI);Pilsicainidehydrochloride;Alisrythm;Sunrythm;Pilsicainide Hydrochloride and intermediates;Pilsicainidehydrochloride(forresearchonly);pilsicaininide;n-(2,6-dimethylphenyl)-2-(1,2,3,5,6,7-hexahydropyrrolizin-8-yl)acetamide hydrochloride; |
| Melting Point: | 212-214° |
| Boiling Point: | 416.9 °C at 760 mmHg |
| Flash Point: | 205.9 °C |
| PSA: | 32.34000 |
| LogP: | 3.27130 |
- 958254-66-51H-Imidazo[4,5-b]pyridine-2-carboxaldehyde, 1-methyl-, hydrochloride
- 99170-93-1N-Methyl-2-oxazolamine
- 914458-26-7[5-(2-fluorophenyl)-1-pentyl-1H-pyrrol-3-yl]-1-naphthalenyl-Methanone
- 894852-01-87-BROMO-2,2-DIMETHYL-2H-PYRIDO[3,2-B][1,4]OXAZIN-3(4H)-ONE
- 90221-55-92-bromo-5-methylbenzaldehyde
- 885590-99-82,3-DIFLUORO-4-IODOBENZALDEHYDE
- 97730-31-9(S)-4'-(2-Methylbutyl)Biphenyl-4-Carbonitrile
- 926293-55-26-Bromo-2-methylpyridine-3-carboxaldehyde
- 911112-05-55-Iodo-3-(trifluoromethyl)-2-pyridinamine
- 886364-50-71-(5-Bromo-2-pyridinyl)-2,2,2-trifluoroethanone
What can I do for you?
Get Best Price
Chemistry
Product Name: Pilsicainide hydrochloride (88069-49-2)
IUPAC Name: N-(2,6-dimethylphenyl)-2-(1,2,3,5,6,7-hexahydropyrrolizin-8-yl)acetamide hydrochloride
Following is the molecular structure of Pilsicainide hydrochloride (88069-49-2):
Molecular Formula: C17H24N2O.HCl
Molecular Weight: 308.85
ACD/LogP: 3.05
of Rule of 5 Violations: 0
ACD/LogD (pH 5.5): 0
ACD/LogD (pH 7.4): 1
ACD/BCF (pH 5.5): 1
ACD/BCF (pH 7.4): 1
ACD/KOC (pH 5.5): 1
ACD/KOC (pH 7.4): 3
H bond acceptors: 3
H bond donors: 1
Freely Rotating Bonds: 3
Polar Surface Area: 23.55 Å2
Flash Point: 205.9 °C
Enthalpy of Vaporization: 67.02 kJ/mol
Boiling Point: 416.9 °C at 760 mmHg
Vapour Pressure: 3.7E-07 mmHg at 25°C
InChI
InChI=1/C17H24N2O.ClH/c1-13-6-3-7-14(2)16(13)18-15(20)12-17-8-4-10-19(17)11-5-9-17;/h3,6-7H,4-5,8-12H2,1-2H3,(H,18,20);1H
Smiles
C1CN2CCCC2(C1)CC(Nc1c(cccc1C)C)=O.Cl
Classification Code: Anti-Arrhythmia Agents; Cardiovascular Agents; Drug / Therapeutic Agent; Membrane Transport Modulators; Sodium Channel Blockers
Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| dog | LD50 | intravenous | 18mg/kg (18mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) CARDIAC: OTHER CHANGES LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Oyo Yakuri. Pharmacometrics. Vol. 42, Pg. 461, 1991. |
| dog | LD50 | oral | 50mg/kg (50mg/kg) | SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE BEHAVIORAL: TREMOR BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) | Arzneimittel-Forschung. Drug Research. Vol. 38, Pg. 1398, 1988. |
| mouse | LD50 | intraperitoneal | 85mg/kg (85mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Oyo Yakuri. Pharmacometrics. Vol. 42, Pg. 457, 1991. |
| mouse | LD50 | intravenous | 17mg/kg (17mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Oyo Yakuri. Pharmacometrics. Vol. 42, Pg. 457, 1991. |
| mouse | LD50 | oral | 175mg/kg (175mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Oyo Yakuri. Pharmacometrics. Vol. 42, Pg. 457, 1991. |
| mouse | LD50 | subcutaneous | 410mg/kg (410mg/kg) | Journal of Medicinal Chemistry. Vol. 28, Pg. 714, 1985. | |
| rabbit | LD50 | oral | 87mg/kg (87mg/kg) | SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE BEHAVIORAL: TREMOR BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) | Arzneimittel-Forschung. Drug Research. Vol. 38, Pg. 1398, 1988. |
| rat | LD50 | intraperitoneal | 105mg/kg (105mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Oyo Yakuri. Pharmacometrics. Vol. 42, Pg. 457, 1991. |
| rat | LD50 | intravenous | 18mg/kg (18mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Oyo Yakuri. Pharmacometrics. Vol. 42, Pg. 457, 1991. |
| rat | LD50 | oral | 255mg/kg (255mg/kg) | BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Oyo Yakuri. Pharmacometrics. Vol. 42, Pg. 457, 1991. |
Safety Profile
Safety of Pilsicainide hydrochloride (CAS NO.88069-49-2): A poison by ingestion, intraperitoneal, intravenous, and subcutaneous routes. When heated to decomposition it emits toxic vapors of NOx, HCl, and Cl−.
Specification
Pilsicainide hydrochloride , with CAS number of 88069-49-2, can be called n-(2,6-dimethylphenyl)-2-(1,2,3,5,6,7-hexahydropyrrolizin-8-yl)acetamide hydrochloride ; Pilsicainide hydrochloride ; pilsicainide hydrochloride hemihydrate ; pilsicaininide ; Pilsicainide hydrochoride ; Pilsicainidehydrochloride(forresearchonly) ; Pilsicainide Hydrochloride and intermediates ; Alisrythm .